What is Canagliflozin's Effects on NT-proBNP and Heart Failure? ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌
Can't see the images? View as webpage.
 
To ensure that you never miss an issue, please whitelist us.
DIABETES IN CONTROL | News and Information for Medical Professionals
DIC_23Years_Badge.png
     

Effectiveness of Blood Glucose Control Protocol for Open-heart Surgery Patients

EFFECTIVENESS OF BLOOD GLUCOSE CONTROL PROTOCOL FOR OPEN-HEART SURGERY PATIENTS
Some studies show the relationship between optimal glucose control in the ICU setting results in fewer days in the hospital, which directly relates to a reduction in mortality. Yale did a study to reduce blood glucose. It was a randomized controlled study to control blood sugar within the intensive care unit.
See More

Risk of Developing Glaucoma in Postmenopausal Women with Diabetes in Korea

The association between diabetes and glaucoma is inconclusive in prior studies. This study is an Institutional Review Board-approved retrospective review of eligible patients utilizing the Korean National Health Insurance Service database, which includes data up to 97% of the nation’s population.
Read More
RISK OF DEVELOPING GLAUCOMA IN POSTMENOPAUSAL WOMEN WITH DIABETES IN KOREA

CANAGLIFLOZIN EFFECTS ON NT-PROBNP AND HEART FAILURE
Canagliflozin Effects on NT-proBNP and Heart Failure

Patients with type 2 diabetes are at risk for many cardiovascular diseases, including heart failure. Which subgroup of patients with type 2 diabetes and heart failure is more beneficial from treatment with canagliflozin?
Learn Here

     

  dic_icon_facebook  dic_icon_twitter   dic_icon_linkedIn

©2022 HIPER, LLC. All rights reserved.

This email was sent by eHealthcare Solutions on behalf of: Diabetes In Control

2093 Philadelphia Pike #8370
Claymont, DE 19703

DiabetesInControl.com | Contact Us |  Update Profile | Unsubscribe